Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure

Canadian Journal of Cardiology

Volumn 25, Issue 10, 2009, Pages

  Duman, Dursun ^a   Palit, Fatih ^a   Simsek, Ergun ^a   Bilgehan, Karadag ^b   Sacide, Atalay ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Decompensated heart failure; Dobutamine; Left atrial function; Levosimendan

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; DOBUTAMINE; FUROSEMIDE; LEVOSIMENDAN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD FLOW VELOCITY; BLOOD SAMPLING; CONTINUOUS INFUSION; CONTROLLED STUDY; DIURETIC THERAPY; DOPPLER ECHOGRAPHY; FEMALE; HEART ATRIUM FUNCTION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PULSE WAVE;

EID: 70350173278     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70721-4     Document Type: Article

References (31)

1. Figgit DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001;61:613-27
2. Innes CA, Wagstaff AJ. Levosimendan: A review of its use in the management of acute decompensated heart failure. Drugs 2003;63:2651-71
3. Slawsky MT, Colucci WS, Gottlieb SS, et al. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 2000;102:2222-7
4. Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 2000;36:1903-12.
5. Follath F, Franco F, Cardoso JS. European experience on the practical use of levosimendan in patients with acute heart failure syndromes. Am J Cardiol 2005;96:80-5.
6. + channel in rat arterial myocytes. Eur J Pharmacol 1997;333:249-59.
7. Kersten JR, Montgomery MW, Paget PS, Warltier DC. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 2000;90:5-11.
8. Haikala H, Kaheinen P, Levijoki J, Linden IB. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res 1997;34:536-46.
9. Mebazaa A, Nieminen MS, Packer M, et al. SURVIVE Investigators. Levosimendan vs dobutamine for patients with acute de-compensated heart failure: The SURVIVE Randomized Trial. JAMA 2007;297:1883-91.
10. Nanas JN, Papazoglou PP, Terrovitis JV, et al. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone. Am J Cardiol 2004;96:1329-32.
11. Barbier P, Solomon SB, Schiller NB, Glantz SA. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function. Circulation 1999;100:427-36
12. Matsuda Y, Toma Y, Ogawa H, et al. Importance of left atrial function in patients with myocardial infarction. Circulation 1983;67:566-71.
13. Murray JA, Kennedy JW, Figley MM. Quantitative angiocardiography. II. The normal left atrial volume in man. Circulation 1968;37:800-4.
14. Hansson L, Hedner T, Dahlof B. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Prospective Randomized Open Blinded End-Point. Blood Press 1992;1:113-9.
15. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Sub-committee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
16. Dodge HT, Sandler H, Ballew DW, Lord DJ Jr. The use of biplane angiocardiography for the measurements of left ventriculat volumes in man. Am Heart J 1960;60;762-76.
17. Rivas-Gotz C, Manolios M, Thohan V, Nagueh SF. Impact of left ventricular ejection fraction on estimation of left ventricular filling pressures using tissue Doppler and flow Propagation velocity. Am J Cardiol 2003;91:780-4.
18. Kono T, Sabbah HN, Rosman H, Alam M, Stein PD, Goldstein S. Left atrial contribution to ventricular filling during the course of evolving heart failure. Circulation 1992;86:1317-22.
19. Appleton CP, Hatle LK. The natural history of left ventricular filling abnormalities: Assessment by two-dimensional and Doppler echocardiography. Echocardiography 1992;9:437-57.
20. Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic pepticle as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135:825-32.
21. Mueller T, Gegenhuber A, Poelz W, Haltmayer M. Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease. Clin Chim Acta 2004;341:41-8.
22. Troughton RW, Prior DL, Pereira JJ, et al. Plasma B-type natriuretic peptide levels in systolic heart failure. Importance of left ventricular diastolic function and right ventricular function. J Am Coll Cardiol 2004:43:416-22.
23. Barclay JL, Kruszewski K, Croal BL, Cuthberuson BH, Oh JK, Hillis GS. Relation of left atrial volume to B-type natriuretic peptide levels in patients with stable chronic heart failure. Am J Cardiol 2006;98:98-101.
24. Adamopoulos S, Parissis JT, Iliodromitis EK, et al. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure. Am J Cardiol 2006;98:102-6.
25. Stefanadis C, Dernellis J, Toutouzas P. A clinical appraisal of left atrial function. Eur Heart 12001;22:22-36.
26. Stefanadis C, Dernellis J, Stratos C, et al. Effects of balloon mitral valvuloplasty on left atrial function in mitral stenosis as assessed by pressure-area relation. J Am Coll Cardiol 1988;32:159-68.
27. 1eft ventricular diastolic function: New insights from a combined hemodynamic and Doppler echocardiographic study. J Am Coll Cardiol 1988;12:426-40.
28. Basnight MA, Gonzalez MS, Kershenovich SC, Appleton CP. Pulmonary venous flow velocity: Relation to hemodynamics, mitral flow velocity and left atrial volume and ejection fraction. J Am Soc Echocardiogr 1991;4:547-58.
29. Barraud D, Faivre V, Damy T, et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: Comparison with dobutamifie and milrinone. Crit Care Med 2007;35:1376-82.
30. Capomolla S, Pozzoli M, Opasich C, et al. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: Hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J 1997;134:1089-98.
31. Duygu H, Ozerkan F, Nalbantgil S, et al. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure. Int J Cardiol 2008;123:201-13.